Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Safety aspects of enterococci from the medical point of view.

Kayser FH.

Int J Food Microbiol. 2003 Dec 1;88(2-3):255-62. Review.

PMID:
14596998
2.

Low specificity of the bacterial index for the diagnosis of bacterial pneumonia by bronchoalveolar lavage.

Speich R, Hauser M, Hess T, Wüst J, Grebski E, Kayser FH, Russi EW.

Eur J Clin Microbiol Infect Dis. 1998 Feb;17(2):78-84.

PMID:
9629970
3.

[Sensitivity of bacteria to therapeutic drugs (Zurich 1996)].

Wüst J, Zbinden R, Kayser FH.

Praxis (Bern 1994). 1998 Mar 18;87(12):403-12. Review. German.

PMID:
9564237
4.

Will cultures survive? The role of molecular tests in diagnostic bacteriology.

Altwegg M, Kayser FH.

Infection. 1997 Sep-Oct;25(5):265-8. No abstract available.

PMID:
9334859
5.

Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Nüesch-Inderbinen MT, Kayser FH, Hächler H.

Antimicrob Agents Chemother. 1997 May;41(5):943-9.

6.

Impact of sar and agr on methicillin resistance in Staphylococcus aureus.

Píriz Durán S, Kayser FH, Berger-Bächi B.

FEMS Microbiol Lett. 1996 Aug 1;141(2-3):255-60.

PMID:
8768531
7.

Prospective evaluation of a semiquantitative dip slide method compared with quantitative bacterial cultures of BAL fluid.

Speich R, Wüst J, Hess T, Kayser FH, Russi EW.

Chest. 1996 Jun;109(6):1423-9.

PMID:
8769488
8.

Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test.

Nüesch-Inderbinen MT, Hächler H, Kayser FH.

Eur J Clin Microbiol Infect Dis. 1996 May;15(5):398-402.

PMID:
8793399
9.
10.
11.

New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases.

Nüesch-Inderbinen MT, Hächler H, Kayser FH.

Antimicrob Agents Chemother. 1995 Aug;39(8):1726-30.

12.

[sensitivity of bacteria to chemotherapeutic agents (Zurich, 1993)].

Wüst J, Kayser FH.

Praxis (Bern 1994). 1995 Jan 24;84(4):98-105. German.

PMID:
7846439
13.
14.

Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus.

Ryffel C, Strässle A, Kayser FH, Berger-Bächi B.

Antimicrob Agents Chemother. 1994 Apr;38(4):724-8.

15.

The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon.

Gustafson J, Strässle A, Hächler H, Kayser FH, Berger-Bächi B.

J Bacteriol. 1994 Mar;176(5):1460-7.

16.

Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V.

Kresken M, Hafner D, Mittermayer H, Verbist L, Bergogne-Bérézin E, Giamarellou H, Esposito S, van Klingeren B, Kayser FH, Reeves DS, et al.

Infection. 1994;22 Suppl 2:S90-8.

PMID:
7927836
17.

Genetic characterization of plasmid-encoded multiple antibiotic resistance in a strain of Listeria monocytogenes causing endocarditis.

Hadorn K, Hächler H, Schaffner A, Kayser FH.

Eur J Clin Microbiol Infect Dis. 1993 Dec;12(12):928-37.

PMID:
8187788
18.

Evolution of resistance in microorganisms of human origin.

Kayser FH.

Vet Microbiol. 1993 Jun;35(3-4):257-67.

PMID:
8212510
19.

Survey of the methicillin resistance-associated genes mecA, mecR1-mecI, and femA-femB in clinical isolates of methicillin-resistant Staphylococcus aureus.

Hürlimann-Dalel RL, Ryffel C, Kayser FH, Berger-Bächi B.

Antimicrob Agents Chemother. 1992 Dec;36(12):2617-21.

20.

Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus.

Berger-Bächi B, Strässle A, Gustafson JE, Kayser FH.

Antimicrob Agents Chemother. 1992 Jul;36(7):1367-73.

21.
22.

Infection in the upper body: hand and burn-wound microbiology and considerations for antimicrobial therapy.

Zellweger G, Simmen HP, Meyer VE, Kayser FH.

J Burn Care Rehabil. 1992 Mar-Apr;13(2 Pt 2):298-304.

PMID:
1577843
23.

Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci.

Ryffel C, Kayser FH, Berger-Bächi B.

Antimicrob Agents Chemother. 1992 Jan;36(1):25-31.

24.

Changes in the spectrum of organisms causing respiratory tract infections: a review.

Kayser FH.

Postgrad Med J. 1992;68 Suppl 3:S17-23. Review.

PMID:
1287613
26.

[Bacterial sensitivity to chemotherapeutic agents (Zurich, 1990)].

Wüst J, Kayser FH.

Schweiz Rundsch Med Prax. 1991 Sep 10;80(37):946-53. German.

PMID:
1925214
27.
28.

Interpretive criteria for disk diffusion susceptibility testing of sparfloxacin.

Kayser FH, Wüst J.

Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):163-6.

PMID:
2060516
29.

Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.

Jacoby GA, Blaser MJ, Santanam P, Hächler H, Kayser FH, Hare RS, Miller GH.

Antimicrob Agents Chemother. 1990 Dec;34(12):2381-6.

30.

[In-vitro activity of cefuroxime-axetil against pathogens of bacterial infections of the respiratory tract].

Kayser FH, Bille J.

Schweiz Rundsch Med Prax. 1990 Nov 6;79(45):1383-6. German.

PMID:
2080392
31.

Prevalence of antimicrobial resistance in Haemophilus influenzae in Greece, Israel, Lebanon and Morocco.

Santanam P, Morenzoni G, Kayser FH.

Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):818-20.

PMID:
2086217
32.

The Second European Collaborative Study on the frequency of antimicrobial resistance in Haemophilus influenzae.

Kayser FH, Morenzoni G, Santanam P.

Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):810-7.

PMID:
2086216
33.

Sequence comparison of mecA genes isolated from methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.

Ryffel C, Tesch W, Birch-Machin I, Reynolds PE, Barberis-Maino L, Kayser FH, Berger-Bächi B.

Gene. 1990 Sep 28;94(1):137-8. No abstract available.

PMID:
2227446
34.

Complete nucleotide sequence of IS431mec in Staphylococcus aureus.

Barberis-Maino L, Ryffel C, Kayser FH, Berger-Bächi B.

Nucleic Acids Res. 1990 Sep 25;18(18):5548. No abstract available.

35.

Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2'.

Tesch W, Ryffel C, Strässle A, Kayser FH, Berger-Bächi B.

Antimicrob Agents Chemother. 1990 Sep;34(9):1703-6.

36.

Use of a ribosomal RNA gene probe for the epidemiological study of methicillin and ciprofloxacin resistant Staphylococcus aureus.

Hadorn K, Lenz W, Kayser FH, Shalit I, Krasemann C.

Eur J Clin Microbiol Infect Dis. 1990 Sep;9(9):649-53.

PMID:
2226492
37.

Mechanism of imipenem resistance acquired by three Pseudomonas aeruginosa strains during imipenem therapy.

Vurma-Rapp U, Kayser FH, Hadorn K, Wiederkehr F.

Eur J Clin Microbiol Infect Dis. 1990 Aug;9(8):580-7.

PMID:
2120059
39.
40.

In vitro activity of oral cephalosporin BAY v 3522 compared with other oral cephalosporins.

Locher R, Strässle A, Kayser FH.

Drugs Exp Clin Res. 1990;16(10):515-25.

PMID:
2100734
41.

FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization.

Berger-Bächi B, Barberis-Maino L, Strässle A, Kayser FH.

Mol Gen Genet. 1989 Oct;219(1-2):263-9.

PMID:
2559314
42.

Activity of meropenem, against gram-positive bacteria.

Kayser FH, Morenzoni G, Strässle A, Hadorn K.

J Antimicrob Chemother. 1989 Sep;24 Suppl A:101-12.

43.

European Cooperative Study of the prevalence of antibiotic resistance in Haemophilus.

Kayser FH, Braveny I, Dabernat H, Dornbusch K, Van Dyck E, Van Klingeren B, Machka K, Mittermaier H, Perea E, Powell M.

J Chemother. 1989 Jul;1(4 Suppl):287-8. No abstract available.

PMID:
16312404
44.

[Bacterial susceptibility to chemotherapeutic agents (Zurich, 1987)].

Wüst J, Kayser FH.

Schweiz Rundsch Med Prax. 1989 Jun 27;78(26):745-50. German.

PMID:
2756266
45.

Natural methicillin resistance in comparison with that selected by in-vitro drug exposure in Staphylococcus aureus.

Berger-Bächi B, Strässle A, Kayser FH.

J Antimicrob Chemother. 1989 Feb;23(2):179-88.

46.

Cloning and expression of methicillin resistance from Staphylococcus epidermidis in Staphylococcus carnosus.

Tesch W, Strässle A, Berger-Bächi B, O'Hara D, Reynolds P, Kayser FH.

Antimicrob Agents Chemother. 1988 Oct;32(10):1494-9.

47.

[Modification of the serum level of cefamandole by massive volume replacement].

Buchmann P, Siebenmann R, Kayser FH, Eijsten A, Geroulanos S.

Helv Chir Acta. 1988 Apr;54(6):763-70. German. No abstract available.

PMID:
3403291
48.

Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study.

Machka K, Braveny I, Dabernat H, Dornbusch K, Van Dyck E, Kayser FH, Van Klingeren B, Mittermayer H, Perea E, Powell M.

Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):14-24. Erratum in: Eur J Clin Microbiol Infect Dis 1988 Jun;7(3):443.

PMID:
3132370
49.

Bacteriological aspects of deep wound sepsis in surgery and orthopedics.

Kayser FH, Strässle A, Vurma U.

Reconstr Surg Traumatol. 1988;20:1-10. No abstract available.

PMID:
3399733
50.

Supplemental Content

Loading ...
Support Center